Rhynchophylline down-regulates nr2b expression in cortex and hippocampal ca1 area of amphetamine-induced conditioned place rat preference

Archives of Pharmacal Research

Volumn 33, Issue 4, 2010, Pages 557-565

  Zhou, Ji Yin ^a   Mo, Zhi Xian ^b   Zhou, Shi Wen ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Amphetamine; Conditioned place preference; Hippocampal CA1 area; Medial prefrontal cortex; NMDA receptor 2B subunit; Rhynchophylline

Indexed keywords

AMPHETAMINE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; RHYNCHOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROL GROUP; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PLACE PREFERENCE; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RAT; REWARD;

AMPHETAMINE; ANIMALS; CA1 REGION, HIPPOCAMPAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DOWN-REGULATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INDOLE ALKALOIDS; MALE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 77954520792     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-010-0410-3     Document Type: Article

References (41)

1. Bardo, M. T. and Bevins, R. A., Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl), 153, 31-43 (2000).
2. Blackburn, J. R. and Szumlinski, K. K., Ibogaine effects on sweet preference and amphetamine induced locomotion: implications for drug addiction. Behav. Brain Res., 89, 99-106 (1997).
3. Bowyer, J. F., Delongchamp, R. R., and Jakab, R. L., Glutamate N-methyl-D-aspartate and dopamine receptors have contrasting effects on the limbic versus the somatosensory cortex with respect to amphetamine-induced neurodegeneration. Brain Res., 1030, 234-246 (2004).
4. Cajetan Luna, G., Use and abuse of amphetamine-type stimulants in the United States of America. Rev. Panam. Salud Publica, 9, 114-122 (2001).
5. Carr, G. D. and White, N. M., Anatomical disassociation of amphetamine's rewarding and aversive effects: an intracranial microinjection study. Psychopharmacology (Berl), 89, 340-346 (1986).
6. Check, E., Psychedelic drugs: the ups and downs of ecstasy. Nature, 429, 126-128 (2004).
7. Glick, S. D., Kuehne, M. E., Raucci, J., Wilson, T. E., Larson, D., Keller, R. W., Jr., and Carlson, J. N., Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum. Brain Res., 657, 14-22 (1994).
8. Glick, S. D., Ramirez, R. L., Livi, J. M., and Maisonneuve, I. M., 18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats. Eur. J. Pharmacol., 537, 94-98 (2006).
9. Goebel, D. J. and Poosch, M. S., NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A. Brain Res. Mol. Brain Res., 69, 164-170 (1999).
10. Hollmann, M. and Heinemann, S., Cloned glutamate receptors. Annu. Rev. Neurosci., 17, 31-108 (1994).
11. Hsu, E. and Packard, M. G., Medial prefrontal cortex infusions of bupivacaine or AP-5 block extinction of amphetamine conditioned place preference. Neurobiol. Learn Mem., 89, 504-512 (2008).
12. Jones, A. L. and Simpson, K. J., Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications. Aliment. Pharmacol. Ther., 13, 129-133 (1999).
13. Jones, E. A., Wang, J. Q., Mayer, D. C., and McGinty, J. F., The role of dorsal striatal GABA(A) receptors in dopamine agonist-induced behavior and neuropeptide gene expression. Brain Res., 836, 99-109 (1999).
14. Kalluri, H. S., Mehta, A. K., and Ticku, M. K., Up-regulation of NMDA receptor subunits in rat brain following chronic ethanol treatment. Brain Res. Mol. Brain Res., 58, 221-224 (1998).
15. Kang, T. H., Murakami, Y., Matsumoto, K., Takayama, H., Kitajima, M., Aimi, N., and Watanabe, H., Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytes. Eur. J. Pharmacol., 455, 27-34 (2002).
16. Kang, T. H., Murakami, Y., Takayama, H., Kitajima, M., Aimi, N., Watanabe, H., and Matsumoto, K., Protective effect of rhynchophylline and isorhynchophylline on in vitro ischemia-induced neuronal damage in the hippocampus: Putative neurotransmitter receptors involved in their action. Life Sci., 76, 331-343 (2004).
17. Karami, M., Zarrindast, M. R., Sepehri, H., and Sahraei, H., Role of nitric oxide in the rat hippocampal CA1 area on mor- phine-induced conditioned place preference. Eur. J. Pharmacol., 449, 113-119 (2002).
18. Kindlundh-Hogberg, A. M., Blomqvist, A., Malki, R., and Schioth, H. B., Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats. BMC Neurosci., 9, 39 (2008).
19. Laurie, D. J., Bartke, I., Schoepfer, R., Naujoks, K., and Seeburg, P. H., Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. Brain Res. Mol. Brain Res., 51, 23-32 (1997).
20. Liao, R. M., Development of conditioned place preference induced by intra-accumbens infusion of amphetamine is attenuated by co-infusion of dopamine D1 and D2 receptor antagonists. Pharmacol. Biochem. Behav., 89, 367-373 (2008).
21. Loftis, J. M. and Janowsky, A., Regulation of NMDA receptor subunits and nitric oxide synthase expression during cocaine withdrawal. J. Neurochem., 75, 2040-2050 (2000).
22. Loftis, J. M. and Janowsky, A., The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol. Ther., 97, 55-85 (2003).
23. Ma, Y. Y., Chu, N. N., Guo, C. Y., Han, J. S., and Cui, C. L., NR2B-containing NMDA receptor is required for morphine-but not stress-induced reinstatement. Exp. Neurol., 203, 309-319 (2007).
24. Maurer, H. H., Kraemer, T., Springer, D., and Staack, R. F., Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. Ther. Drug Monit., 26, 127-131 (2004).
25. Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., and Seeburg, P. H., Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron, 12, 529-540 (1994).
26. Mora, F. and Porras, A., Effects of amphetamine on the release of excitatory amino acid neurotransmitters in the basal ganglia of the conscious rat. Can. J. Physiol. Pharmacol., 71, 348-351 (1993).
27. Mori, H. and Mishina, M., Structure and function of the NMDA receptor channel. Neuropharmacology, 34, 1219-1237 (1995).
28. Moyano, S., Del Rio, J., and Frechilla, D., Acute and chronic effects of MDMA on molecular mechanisms implicated in memory formation in rat hippocampus: surface expression of CaMKII and NMDA receptor subunits. Pharmacol. Biochem. Behav., 82, 190-199 (2005).
29. Narita, M., Aoki, T., and Suzuki, T., Molecular evidence for the involvement of NR2B subunit containing N-methyl-Daspartate receptors in the development of morphine-induced place preference. Neuroscience, 101, 601-606 (2000).
30. Nomikos, G. G. and Spyraki, C., Cocaine-induced place conditioning: importance of route of administration and other procedural variables. Psychopharmacology (Berl), 94, 119-125 (1988).
31. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, C. A., pp. 25-80, (1998).
32. Robinson, T. E. and Berridge, K. C., The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev., 18, 247-291 (1993).
33. Schmidt, C. J., Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther., 240, 1-7 (1987).
34. Shi, J. S., Yu, J. X., Chen, X. P., and Xu, R. X., Pharmacological actions of Uncaria alkaloids, rhynchophylline and isorhynchophylline. Acta Pharmacol. Sin., 24, 97-101 (2003).
35. Shimada, Y., Goto, H., Itoh, T., Sakakibara, I., Kubo, M., Sasaki, H., and Terasawa, K., Evaluation of the protective effects of alkaloids isolated from the hooks and stems of Uncaria sinensis on glutamate-induced neuronal death in cultured cerebellar granule cells from rats. J. Pharm. Pharmacol., 51, 715-722 (1999).
36. Tyhon, A., Lakaye, B., Adamantidis, A., and Tirelli, E., Amphetamine-and cocaine-induced conditioned place preference and concomitant psychomotor sensitization in mice with genetically inactivated melanin-concentrating hormone MCH(1) receptor. Eur. J. Pharmacol., 599, 72-80 (2008).
37. Tzschentke, T. M., Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol., 12, 227-462 (2007).
38. Tzschentke, T. M. and Schmidt, W. J., Blockade of morphineand amphetamine-induced conditioned place preference in the rat by riluzole. Neurosci. Lett., 242, 114-116 (1998).
39. Wang, Y. H., Bosy, T. Z., Yasuda, R. P., Grayson, D. R., Vicini, S., Pizzorusso, T., and Wolfe, B. B., Characterization of NMDA receptor subunit-specific antibodies: distribution of NR2A and NR2B receptor subunits in rat brain and ontogenic profile in the cerebellum. J. Neurochem., 65, 176-183 (1995).
40. White, F. J., Hu, X. T., Zhang, X. F., and Wolf, M. E., Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J. Pharmacol. Exp. Ther., 273, 445-454 (1995).
41. Yamada, K., Endogenous modulators for drug dependence. Biol. Pharm. Bull., 31, 1635-1638 (2008).